Xiaolin Wan

3.0k citations

28 papers · 2.4k indexed · 2 hit papers · h-index 17

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research

Papers in ⓘ

Immunology and Allergy 4
- Cell Adhesion Molecules Research 4
Pulmonary and Respiratory Medicine 9
- Sarcoma Diagnosis and Treatment 8

Co-authors: Lee J. Helman (16 shared papers)Chand Khanna (5 shared papers)Arnulfo Mendoza (6 shared papers)Patrick J. Grohar (2 shared papers)Choh Yeung (7 shared papers)Stephen M. Hewitt (2 shared papers)Richard Görlick (1 shared paper)Ryan D. Cassaday (1 shared paper)
Journals: Oncogene (5 papers)Cancer Research (5 papers)Neoplasia (3 papers)Physical review. B. (2 papers)Biogerontology (1 paper)
Partner nations: United States China Thailand

In The Last Decade

Xiaolin Wan

26 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism 2006 · 630 citations

Peers

Countries citing papers authored by Xiaolin Wan

Since Specialization

Citations

This map shows the geographic impact of Xiaolin Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Wan more than expected).

Fields of papers citing papers by Xiaolin Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Wan. The network helps show where Xiaolin Wan may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaolin Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaolin Wan Line = papers co-authored together Xiaolin Wan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism Oncogene ·Xiaolin Wan, B Harkavy, (unknown), Patrick J. Grohar, Lee J. Helman Hit paper breakdown →	2006	630
2	The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nature Medicine ·Chand Khanna, Xiaolin Wan, Seuli Bose, Ryan D. Cassaday, Osarenoma Olomu, Arnulfo Mendoza, Choh Yeung, Richard Görlick, Stephen M. Hewitt, Lee J. Helman Hit paper breakdown →	2004	572
3	Phosphoprotein Pathway Mapping: Akt/Mammalian Target of Rapamycin Activation Is Negatively Associated with Childhood Rhabdomyosarcoma Survival Cancer Research ·Emanuel F. Petricoin, Virginia Espina, Robyn P. Araujo, Brieanne Midura, Choh Yeung, Xiaolin Wan, Gabriel S. Eichler, Donald J. Johann, Stephen J. Qualman, Maria Tsokos, Kartik Krishnan, Lee J. Helman, Lance A. Liotta	2007	196
4	Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma Cancer Research ·Xiaolin Wan, Arnulfo Mendoza, Chand Khanna, Lee J. Helman	2005	171
5	The Biology Behind mTOR Inhibition in Sarcoma The Oncologist ·Xiaolin Wan, Lee J. Helman	2007	146
6	Addiction to Elevated Insulin-like Growth Factor I Receptor and Initial Modulation of the AKT Pathway Define the Responsiveness of Rhabdomyosarcoma to the Targeting Antibody Cancer Research ·Liang Cao, Yunkai Yu, Isaac Darko, Duane Currier, Linnia H. Mayeenuddin, Xiaolin Wan, Chand Khanna, Lee J. Helman	2008	122
7	CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling Neoplasia ·Xiaolin Wan, Na Shen, Arnulfo Mendoza, Chand Khanna, Lee J. Helman	2006	122
8	Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells Oncogene ·Xiaolin Wan, Lee J. Helman	2003	94
9	Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin Oncogene ·Xiaolin Wan, So Young Kim, Lillian M. Guenther, Arnulfo Mendoza, J. H. Briggs, C. Y. Yeung, Duane Currier, H Zhang, Crystal L. Mackall, W-J Li, Rocky S. Tuan, Andrea T. Deyrup, C. Khanna, Lee J. Helman	2009	62
10	Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma Cancer Research ·Xiaolin Wan, Choh Yeung, Su Young Kim, J. Gregory Dolan, Vu N. Ngo, Sandra Burkett, Javed Khan, Louis M. Staudt, Lee J. Helman	2012	42
11	Effect of Insulin-Like Growth Factor II on Protecting Myoblast Cells Against Cisplatin-Induced Apoptosis Through p70 S6 Kinase Pathway Neoplasia ·Xiaolin Wan, Lee J. Helman	2002	42
12	IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma Neoplasia ·Xiaolin Wan, Choh Yeung, Christine M. Heske, Arnulfo Mendoza, Lee J. Helman	2015	40
13	Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth Oncogene ·Choh Yeung, Vu N. Ngo, Patrick J. Grohar, Fernanda I. Arnaldez, A Asante, Xiaolin Wan, Javed Khan, Stephen M. Hewitt, C. Khanna, Louis M. Staudt, Lee J. Helman	2013	36
14	Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma Oncogene ·Patience Odeniyide, Marielle E. Yohe, Kai Pollard, Angelina V. Vaseva, Ana Calizo, Lindy Zhang, Fausto J. Rodríguez, John Gross, Amy N. Allen, Xiaolin Wan, Romel Somwar, Karisa C. Schreck, Linda Kessler, Jiawan Wang, Christine A. Pratilas	2022	28
15	Topological Electronic Transition Contributing to Improved Thermoelectric Performance in p‐Type Mg₃Sb₂₋_xBi_x Solid Solutions Advanced Materials ·Hongyao Xie, Xiaolin Wan, Yasong Wu, Chunxia Li, Fan Yan, Yujie Ouyang, Haoran Ge, Xianda Li, Yong Liu, Rui Wang, Michael Y. Toriyama, G. Jeffrey Snyder, Jiong Yang, Qingjie Zhang, Wei Liu, Xinfeng Tang	2024	21
16	Rational Manipulation of Epitaxial Strains Enabled Valence Band Convergence and High Thermoelectric Performances in Mg₃Sb₂ Films Advanced Functional Materials ·Hongyao Xie, Wei Liu, Xiaolin Wan, Jianan Lyu, Fan Yan, Yujie Ouyang, Xianda Li, Yong Liu, Ziyu Wang, Rui Wang, Jinsong Wu, Qingjie Zhang, Xinfeng Tang	2023	19
17	Targeting IGF-1R in the treatment of sarcomas: past, present and future Bulletin du Cancer ·Su Young Kim, Xiaolin Wan, Lee J. Helman	2009	16
18	Synthetic retinoid CD437 induces apoptosis of esophageal squamous HET-1A cells through the caspase-3-dependent pathway. PubMed ·Xiaolin Wan, Mark D. Duncan, Petra H. Nass, John W. Harmon	2001	14
19	SIRT4 in ageing Biogerontology ·Ling He, Qingcheng Liu, Jielong Cheng, Mei Cao, Shuaimei Zhang, Xiaolin Wan, Jian Li, Huaijun Tu	2023	13
20	The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma Translational Oncology ·Christine M. Heske, Choh Yeung, Arnulfo Mendoza, Joshua T. Baumgart, Leah D. Edessa, Xiaolin Wan, Lee J. Helman	2016	10

About Xiaolin Wan

Xiaolin Wan is a scholar working on Immunology and Allergy, Pulmonary and Respiratory Medicine, Hematology, Geriatrics and Gerontology and Molecular Biology, having authored 28 papers that have together received 2.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Cell Adhesion Molecules Research (4 papers), Topological Materials and Phenomena (3 papers), Advanced Thermoelectric Materials and Devices (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Advanced Condensed Matter Physics (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Cancer Research (420 citations), Immunology and Allergy (160 citations), Pulmonary and Respiratory Medicine (742 citations), Molecular Biology (1.5k citations) and Oncology (549 citations). Xiaolin Wan has collaborated with scholars based in United States, China and Thailand. Frequent co-authors include Lee J. Helman, Chand Khanna, Arnulfo Mendoza, Patrick J. Grohar, Choh Yeung, Stephen M. Hewitt, Richard Görlick, Ryan D. Cassaday, Osarenoma Olomu and Na Shen. Their work appears in journals such as Oncogene, Cancer Research, Neoplasia, Physical review. B. and Biogerontology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact